SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

SunTrust Robinson Humphrey Initiates Coverage On BioXcel Therapeutics with Buy Rating, Announces $24 Price Target

SunTrust Robinson Humphrey initiates coverage on BioXcel Therapeutics (NASDAQ:BTAI) with a Buy rating and a $24 price target.

Benzinga · -

SunTrust Robinson Humphrey initiates coverage on BioXcel Therapeutics (NASDAQ:BTAI) with a Buy rating and a $24 price target.